Related Experiment Video
Updated: Jun 3, 2025

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
A Standardized Approach to Transition Improves Care of Young Adults with Inflammatory Bowel Disease
Daphna Katz1,2, Stephanie Lee2,3, Vidiya Sathananthan2,3
1From the Division of Pediatric Gastroenterology, Hepatology and Nutrition, University of Miami, Miami, Fla.
Insights
Improving the transition of care for young adults with inflammatory bowel disease (IBD) is crucial. Interventions increased transition discussions and transfer initiation rates, enhancing patient care without increasing visit duration.
Area of Science:
- Gastroenterology
- Pediatric Healthcare
- Transition of Care Medicine
Background:
- Young adults with inflammatory bowel disease (IBD) face risks of poor outcomes during the transition from pediatric to adult healthcare providers.
- Effective care transition strategies are essential to mitigate these risks and ensure continuity of care.
Purpose of the Study:
- To increase the percentage of patients aged 14-17 undergoing care transition and patients aged 18-21 initiating transfer to adult IBD providers.
- To enhance patient satisfaction with the care transition process.
- To ensure the duration of IBD visits does not increase as a balancing measure.
Main Methods:
- Implementation of three interventions using iterative plan-do-study-act cycles over 12 months.
- Statistical process control charts were used to analyze intervention impact.
- Anonymous electronic health record-based satisfaction surveys were administered.
Main Results:
- Total transition discussions increased to a mean of 38%.
- Initiation of transfer of care for patients aged 18-21 increased significantly, reaching a mean of 30% after the second and third interventions.
- No significant difference in IBD visit duration was observed (P = 0.54), and patient satisfaction remained high.
Conclusions:
- The implemented interventions represent successful initial steps in a new process for transitioning young adults with IBD.
- Improved transition discussion and transfer initiation rates were achieved.
- The study highlights the feasibility of enhancing IBD care transitions for young adults.
Introduction:
Young adults with inflammatory bowel disease (IBD) are at the risk of poor outcomes when transferring to adult providers. We aimed to increase the percentage of patients with 14-17 years of age undergoing the transition of care and the percentage of patients 18-21 years of age initiating the transfer of care to 50% for 12 months. Our goal was also to improve patient satisfaction with the transfer process. Our balancing measure was not to increase the duration of IBD visits.
Methods:
We implemented 3 interventions through iterative plan-do-study-act cycles. To understand the impact of the interventions for 12 months, we used statistical process control charts. The duration of IBD visits was used as a balancing measure. We administered an anonymous satisfaction survey through the electronic health record.
Results:
Total transition discussions increased to a mean of 38% (n = 68). Transition discussions with patients 14-17 years of age increased from baseline, though not consistently. Patients 18-21 years of age initiating transfer of care increased to a mean of 5% (n = 1) following the first intervention and to a mean of 30% (n = 13) following our second and third interventions with special cause variation. There was no significant difference in the duration of IBD visits before and after the intervention period (P = 0.54). No patients were dissatisfied following our interventions.
Conclusions:
We saw improved transition discussions and transfer initiation rates by implementing the first steps of a new process to transition young adults with IBD.
More Related Videos
08:37Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
08:27Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
Published on: September 20, 2018
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...